Back

Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Fine-tuning prognostication after acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Adriana Fonseca Vazao

Leiria Hospital Centre, Leiria (Portugal)

4 More presentations in this session

Presentation thumbnail
Coronary artery plaque characteristics in smokers assessed by intracoronary multi-modality imaging: a NIRS-IVUS guided PROSPECT II substudy
Doctor A. Dahlgren (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Advancing prognostic insights in STEMI patients through microvascular resistance reserve evaluation
Doctor T. Tsai (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Association of PCSK6 rs1531817(C/A) polymorphism with the prognosis and coronary stenosis in premature myocardial infarction patients: a prospective cohort study
Professor J. Gao (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Minimal coronary microvascular resistance: agreement between continuous and bolus thermodilution
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Fine-tuning prognostication after acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries
thumbnail
Congress Presentation
Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study
thumbnail
Congress Presentation
Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources